Clinical Trial

Phase I Clinical Trial of Adsorbed Tetanus Vaccine

Name: Phase I Clinical Trial of Adsorbed Tetanus Vaccine — clinical trial record (NCT07598890)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, parallel-controlled Phase I clinical trial of Adsorbed Tetanus Vaccine. Participants aged ≥18 years will receive one dose of the vaccine to evaluate its safety and immunogenicity.

Protocol Amendment History 1 change

critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-08-15

Trial Details

NCT Number	NCT07598890
Lead Sponsor	Aimei Vacin BioPharm (Zhejiang) Co., Ltd.
Conditions	Tetanus
Enrollment	80 participants
Start Date	2026-05-21
Primary Completion	2026-12-21 (estimated)
Study Completion	2027-03-21 (estimated)
Updated on ClinicalTrials.gov	2026-08-14